|
1
|
Chan V, Fenning A, Iver A, et al:
Resveratol improves cardiovascular function in DOCA-salt
hypertensive rats. Curr Pharm Biotechnol. 12:429–436. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang L, Gu Y, Ye J, Liu F, et al:
Resveratrol prevents hepatic steatosis induced by hepatitis C virus
core protein. Biotechnol Lett. 34:2205–2212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang F, Liu J and Shi JS:
Anti-inflammatory activities of resveratrol in the brain: role of
resveratrol in microglial activation. Eur J Pharmacol. 25:1–7.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin JN, Lin VC, Rau KM, et al: Resveratrol
modulates tumor cell proliferation and protein translation via
SIRT1-dependent AMPK activation. J Agric Food Chem. 58:1584–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang F, Wu XN, Chen J, et al: Resveratrol
reverses multidrug resistance in human breast cancer
doxorubicin-resistant cells. Exp Ther Med. 7:1611–1616.
2014.PubMed/NCBI
|
|
6
|
Fulda S: Resveratrol and derivatives for
the prevention and treatment of cancer. Drug Discov Today.
15:757–765. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calabrese EJ, Mattson MP and Calabrese V:
Dose response biology: the case of resveratrol. Hum Exp Toxicol.
29:1034–1037. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SJ, Ahmad F, Philp A, et al:
Resveratrol ameliorates aging-related metabolic phenotypes by
inhibiting cAMP phosphodiesterases. Cell. 148:421–433. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bishayee A, Politis T and Darvesh AS:
Resveratrol in the chemoprevention and treatment of hepatocellular
carcinoma. Cancer Treat Rev. 36:43–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bishayee A: Cancer prevention and
treatment with resveratrol: from rodent studies to clinical trials.
Cancer Prev Res (Philia). 2:409–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsiao YP, Yu CS, Yu CC, et al: Triggering
apoptotic death of human malignant melanoma a375.s2 cells by
bufalin: Involvement of caspase cascade-dependent and independent
mitochondrial signaling pathways. Evi Based Complemen Alternat Med.
2012:5912412012.
|
|
12
|
Kuo JH, Chu YL, Yang JS, et al:
Cantharidin induces apoptosis in human bladder cancer TSGH 8301
cells through mitochondria-dependent signal pathways. Int J Oncol.
37:1243–1250. 2010.PubMed/NCBI
|
|
13
|
Vazquez A, Bond EE, Levine AJ and Bond GL:
The genetics of the p53 pathway, apoptosis and cancer therapy. Nat
Rev Drug Discov. 7:979–987. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brady CA, Jiang D, Mello SS, et al:
Distinct p53 transcriptional programs dictate acute DNA-damage
responses and tumor suppression. Cell. 145:571–583. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chee JL, Saidin S, Lane DP, et al:
Wild-type and mutant p53 mediate cisplatin resistance through
interaction and inhibition of active caspase-9. Cell Cycle.
12:278–288. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gu H, Rao S, Zhao J, et al: Gambogic acid
reduced bcl-2 expression via p53 in human breast MCF-7 cancer
cells. J Cancer Res Clin Oncol. 135:1777–1782. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu B, Zhou Z, Zhou W, et al: Resveratrol
inhibits proliferation in human colorectal carcinoma cells by
inducing G1/S-phase cell cycle arrest and apoptosis through
caspase/cyclin-CDK pathways. Mol Med Rep. 10:1697–1702.
2014.PubMed/NCBI
|
|
18
|
Li P, Yang S, Dou M, et al: Synergic
effects of artemisinin and resveratrol in cancer cells. J Cancer
Res Clin Oncol. 2014:Epub ahead of print. 2014.
|
|
19
|
Zhang P, Li H, Yang B, et al: Biological
significance and therapeutic implication of resveratrol-inhibited
Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes
Cancer. 5:154–64. 2014.PubMed/NCBI
|
|
20
|
Szekeres T, Saiko P, Fritzer-Szekeres M,
Djavan B and Jäger W: Chemopreventive effects of resveratrol and
resveratrol derivatives. Ann NY Acad Sci. 1215:89–95. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nutakul W, Sobers HS, Qiu P, et al:
Inhibitory effects of resveratrol and pterostilbene on human colon
cancer cells: a side-by-side comparison. J Agric Food Chem.
59:10964–10970. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Piotrowska H, Kucinska M and Murias M:
Biological activity of piceatannol: Leaving the shadow of
resveratrol. Mutat Res. 750:60–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Um JH, Park SJ, Kang H, et al:
AMP-activated protein kinase-deficient mice are resistant to the
metabolic effects of resveratrol. Diabetes. 59:554–563. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Liu H, Jin J, Zhu X, Lu L and
Jiang H: The role of endogenous reactive oxygen species in
oxymatrine-induced caspase-3-dependent apoptosis in human melanoma
A375 cells. Anticancer Drugs. 21:494–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyata M, Kambe M, Tajima O, et al:
Membrane sialidase NEU3 is highly expressed in human melanoma cells
promoting cell growth with minimal changes in the composition of
gangliosides. Cancer Sci. 102:2139–2149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tasyriq M, Najmuldeen IA, In LL, Mohamad
K, Awang K and Hasima N: 7 alpha-Hydroxy-beta-Sitosterol from
Chisocheton tomentosus induces apoptosis via dysregulation
of cellular Bax/Bcl-2 ratio and cell cycle arrest by downregulating
ERK1/2 activation. Evid Based Complement Alternat Med.
2012:7653162012.PubMed/NCBI
|
|
27
|
Wu S, Liu B, Zhang Q, et al:
Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma
HepG2 cells. PloS One. 8:e768862013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu HB, Yang K, Xie YQ, Lin YW, Mao QQ and
Xie LP: Silencing of mutant p53 by siRNA induces cell cycle arrest
and apoptosis in human bladder cancer cells. World J Surg Oncology.
11:222013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yeudall WA, Wrighton KH and Deb S: Mutant
p53 in cell adhesion and motility. Methods Mol Biol. 962:135–146.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Voskamp P, Bodmann CA, Koehl GE, et al:
Dietary immunosuppressants do not enhance UV-induced skin
carcinogenesis, and reveal discordance between p53-mutant early
clones and carcinomas. Cancer Prev Res. 6:129–138. 2013. View Article : Google Scholar
|
|
31
|
Lee JH, Gaddameedhi S, Ozturk N, Ye R and
Sancar A: DNA damage-specific control of cell death by cryptochrome
in p53-mutant ras-transformed cells. Cancer Res. 73:785–791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
